Melissa Siegfried

DNP Doctor of Nursing Practice,  Mayo Clinic - Rochester 

Location: Africa

Consulting Services

IT-Web-Mobile Technology Pharma-CRO-Device

Areas Of Interest

Elements, Group 16 Deferasirox AE1 Cl HCO3 Exchanger Surgical Procedure, Oral Vitelliform Macular Dystrophy, Early-Onset Eleutherococcus senticosus Behavior, Smoking G-Quadruplexes RNA Keratin-7 gp100 Melanoma Antigen Mandible Atriopeptigen Sequence Analyses, DNA Drugs, Anti-Anxiety MAP Kinases, Extracellular Signal Regulated Cryotherapies Glycosidases alpha Adaptins Naloxon-Ratiopharm v-fms Gene Disease, Genetic PF 2341066 Mappings, Physical Chromosome

Professional Narrative

Dr. Melissa Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Mayo Clinic 2013
Executive Director, Mayo Clinic 1989

Education

Master of Science in physician assistant, Harvard Medical School 1987
Doctor of osteopathic medicine, Yale School of Medicine 2009

Referees


Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :